Lehnart S E, Janssen P M, Franz W M, Donahue J K, Lawrence J H, Marbán E, Prestle J, Hasenfuss G
Abteilung Kardiologie und Pneumologie, Universität Göttingen, D-37075 Göttingen, Germany.
Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H986-91. doi: 10.1152/ajpheart.2000.279.3.H986.
Adenoviral gene transfer to the heart represents a promising model for structure-function analyses. Rabbit hearts were subjected to an ex vivo perfusion protocol that achieves gene transfer in >90% of cardiac myocytes. Contractile function of isolated myocardial preparations of these hearts was then observed for 2 days in a recently developed trabecula culture system. In sham-infected hearts, the initial developed force (F(init)) (15.6 +/- 3.7 mN/mm(2); n = 12) did not change significantly after 48 h (17.0 +/- 1.9 mN/mm(2); P = 0.46). In adenovirus-infected preparations, F(init) (14.3 +/- 1. 8 mN/mm(2); n = 21) did not significantly differ from the control (P = 0.75) and was unchanged after 48 h (15.3 +/- 2.5 mN/mm(2); P = 0. 93). After 2 days of continuous contractions, we observed homogenous and high-level expression of the reporter genes LacZ coding for beta-galactosidase and Luc coding for firefly luciferase. Luciferase activity increased more than 2,500-fold from background levels of 8. 7 x 10(3 )+/- 5.0 x 10(3) relative light units (RLU)/mg protein (from hearts transfected with promotorless adenovirus with luciferase transgene construct AdNULLLuc, n = 5) to 23.4 x 10(6)+/- 11.1 x 10(6)RLU/mg protein (from hearts tranfected with adenovirus with Rous sarcoma virus promotor and luciferase transgene construct AdRSVLuc, n = 5) in infected myocardial preparations (P < 0.005). Our results demonstrate a new ex vivo approach to achieve homogenous and high-level expression of recombinant adenoviral genes in contracting myocardium without adverse functional effects.
腺病毒介导的基因转移至心脏是一种用于结构-功能分析的很有前景的模型。对兔心脏实施一种离体灌注方案,该方案可使超过90%的心肌细胞实现基因转移。然后,在最近开发的小梁培养系统中对这些心脏的分离心肌制剂的收缩功能进行了2天的观察。在假感染心脏中,初始发育力(F(init))(15.6±3.7 mN/mm²;n = 12)在48小时后(17.0±1.9 mN/mm²;P = 0.46)没有显著变化。在腺病毒感染的制剂中,F(init)(14.3±1.8 mN/mm²;n = 21)与对照组无显著差异(P = 0.75),且在48小时后未改变(15.3±2.5 mN/mm²;P = 0.93)。在持续收缩2天后,我们观察到编码β-半乳糖苷酶的报告基因LacZ和编码萤火虫荧光素酶的Luc的均匀且高水平表达。荧光素酶活性从背景水平8.7×10³±5.0×10³相对光单位(RLU)/mg蛋白质(来自用无启动子腺病毒与荧光素酶转基因构建体AdNULLLuc转染的心脏,n = 5)增加到23.4×10⁶±11.1×10⁶ RLU/mg蛋白质(来自用带有劳斯肉瘤病毒启动子和荧光素酶转基因构建体AdRSVLuc的腺病毒转染的心脏,n = 5),在感染的心肌制剂中(P < 0.005)。我们的结果证明了一种新的离体方法,可在收缩的心肌中实现重组腺病毒基因的均匀且高水平表达,而无不良功能影响。